Investment Research & Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.96M Buy
7,451
+90
+1% +$92K 2.77% 6
2026
Q1
$6.79M Buy
7,361
+50
+0.7% +$50.7K 2.37% 9
2025
Q4
$7.87M Buy
7,311
+31
+0.4% +$29.6K 2.61% 8
2025
Q3
$5.57M Buy
7,280
+172
+2% +$128K 1.89% 14
2025
Q2
$5.54M Buy
7,108
+411
+6% +$319K 2.06% 12
2025
Q1
$5.53M Buy
6,697
+209
+3% +$174K 2.31% 11
2024
Q4
$5.01M Buy
6,488
+64
+1% +$53K 2.08% 13
2024
Q3
$5.69M Sell
6,424
-11
-0.2% -$9.89K 2.4% 9
2024
Q2
$5.83M Buy
6,435
+166
+3% +$133K 2.58% 8
2024
Q1
$4.88M Buy
6,269
+3,048
+95% +$2.17M 2.24% 11
2023
Q4
$1.88M Buy
3,221
+168
+6% +$98.1K 0.96% 30
2023
Q3
$1.64M Buy
3,053
+64
+2% +$33K 0.93% 35
2023
Q2
$1.4M Hold
2,989
0.81% 38
2023
Q1
$1.03M Hold
2,989
0.66% 41
2022
Q4
$1.09M Hold
2,989
0.72% 34
2022
Q3
$966K Hold
2,989
0.72% 38
2022
Q2
$969K Hold
2,989
0.7% 37
2022
Q1
$856K Buy
2,989
+32
+1% +$8.23K 0.54% 38
2021
Q4
$817K Buy
2,957
+562
+23% +$142K 0.5% 38
2021
Q3
$556K Sell
2,395
-26
-1% -$6.42K 0.37% 46
2021
Q2
$556K Buy
2,421
+26
+1% +$5.22K 0.37% 44
2021
Q1
$447K Hold
2,395
0.33% 42
2020
Q4
$404K Hold
2,395
0.3% 43
2020
Q3
$355K Hold
2,395
0.29% 42
2020
Q2
$389K Hold
2,395
0.35% 42
2020
Q1
$332K Hold
2,395
0.31% 40
2019
Q4
$315K Buy
+2,395
New +$278K 0.29% 39

Other funds holding LLY

Investment Research & Advisory Group's LLY Position: Q2 2026 in Review

Investment Research & Advisory Group increased its Eli Lilly (LLY) stake by 1.2% in Q2 2026, buying an estimated $92K and bringing the position to 7,451 shares worth $8.96M. The position accounts for 2.77% of the portfolio, ranked #6.

Investment Research & Advisory Group first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 1,862 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Investment Research & Advisory Group held 7,451 shares of Eli Lilly worth $8.96M as of Q2 2026.
  • Investment Research & Advisory Group bought 90 Eli Lilly shares in Q2 2026, an estimated $92K.
  • Eli Lilly made up 2.77% of Investment Research & Advisory Group's portfolio in Q2 2026, its #6 holding.
  • Investment Research & Advisory Group first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 1,862 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Investment Research & Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.